SAN DIEGO, CA, May 01, 2012 (MARKETWIRE via COMTEX) --Senomyx, Inc. (NASDAQ: SNMX), a company using proprietary taste
science technologies to discover and develop novel flavor ingredients
for the food, beverage, and ingredient supply industries, announced
today that Kent Snyder, the Company's Chief Executive Officer, and
Tony Rogers, Senior Vice President & Chief Financial Officer, will
present a corporate overview on Tuesday, May 8 at 4:10 p.m. Eastern
Time (1:10 p.m. Pacific Time) during the Deutsche Bank 37th Annual
Health Care Conference. The conference is taking place at the
InterContinental Boston in Boston, MA. During the presentation, Mr.
Snyder and Mr. Rogers will discuss corporate developments including
the Company's pipeline of novel flavor ingredients and its business
strategy.
To access the live presentation or a subsequent archived recording,
please log onto Senomyx's website at http://www.senomyx.com and click
on the "Investor Relations" tab. The archived webcast will be
available for 30 days following the presentation. Please connect to
Senomyx's website prior to the start of the webcast to ensure
adequate time to download any software that may be necessary.
About Senomyx, Inc. (www.senomyx.com)
Senomyx is using proprietary
taste science technologies to discover and develop novel flavor
ingredients. These include new flavors such as Savory Flavors and
Cooling Flavors, as well as flavor modulators such as Bitter Blockers
and enhancers of Sweet and Salt tastes. Senomyx is also engaged in a
new effort to discover and develop natural high-potency sweeteners.
The Company has collaborative agreements with global food, beverage,
and ingredient supply companies, some of which are currently
marketing products that contain Senomyx's flavor ingredients. Its
corporate socially responsible activities are described on the
Senomyx Cares blog at http://www.senomyx-csrblog.com/. For more
information, please visit www.senomyx.com.
Contact:
Gwen Rosenberg
Senomyx, Inc.
Vice President, Investor Relations & Corporate Communications
858-646-8369
gwen.rosenberg@senomyx.com
SOURCE: Senomyx, Inc.
mailto:gwen.rosenberg@senomyx.com
